StonvexLoading…
StonvexStonvexStonvexCore line items from REPX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $391.98M | $410.18M | $375.05M | $321.74M |
Operating Income | $133.28M | $153.69M | $171.89M | $203.52M |
Net Income | $160.84M | $88.90M | $111.59M | $118.01M |
EPS (Diluted) | $7.59 | $4.26 | $5.58 | $5.99 |
Total Assets | $1.17B | $993.50M | $945.71M | $515.29M |
Total Liabilities | $535.34M | $482.89M | $524.12M | $181.85M |
Cash & Equivalents | $17.89M | $13.12M | $15.32M | $13.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 21.72M | 21.48M | 20.41M | 20.16M |